Clinical Trial of tipifarnib in HRAS Positive Advanced Squamous Cell Cancer
A clinical trial of an investigational new drug, tipifarnib, is currently enrolling adults WITH hras positive ADvanced squamous cell cancer
WHO: Adults with HRAS Positive Advanced Squamous Cell Cancer
WHAT: A clinical trial for an investigational new drug, tipifarnib
TRAVEL EXPENSES: Qualified participants in this clinical trial may be reimbursed for related travel, as applicable
PLEASE COMPLETE THIS FORM TO BE CONSIDERED FOR PARTICIPATION:
Thank you for your submission. If you qualify, a nurse case manager will call or email you.